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Summary 
We describe mice that express a transgenic T  cell receptor o~/B (TCR-o~/B) specific for peptide 
111-119  from  influenza  hemagglutinin  presented  by  I-E  a  class  II  major  histocompatibility 
complex (MHC) molecules. The transgenic TCR is expressed on CD4 +8-  as well as CD4-8 + 
mature T  cells even in mice that  are deficient in rearrangement  or do not express endogenous 
TCR.-ol genes. The CD4-8 + T cells require I-E  a class II MHC molecules for positive selection 
and can be activated to proliferate and to kill by I-E  a molecules presenting the relevant peptide. 
Full maturation  of these cells,  however, also requires the presence of class I MHC molecules. 
The results are compatible with the notion that T cell maturation requires multiple receptor-ligand 
interactions  and establish an exception to the rule that class II-restricted TCRs are exclusively 
expressed by mature  CD4+8-  cells. 
E 
xperiments  in various TCR-o~/~  transgenic  mice have 
indicated a strict correlation of CD4 or CD8 coreceptor 
expression and presence of class II and class I MHC-restricted 
TCR-a/ffs,  respectively, in mature T  cells (1-4). However, 
in the thymus of TCR transgenic mice, CD4 +8  l~  cells with 
a class I MHC-restricted TCR could be detected (5). Like- 
wise CD41~  ~t cells have been seen in both normal 
and B2-microglobulin  (/~2m)  1 deficient mice (6).  It was ar- 
gued that these cells represented immature precursors of mature 
CD4§  -  and  CD4-8 +  cells,  respectively,  but  that  they 
could not  develop further  because the  coreceptor and the 
TCR-oJ/3 could not be coengaged by the same MHC mole- 
cule. Experiments consistent with this notion showed that 
a CD4 transgene could apparently rescue a population with 
heterogeneous levels of CD8 coreceptors expressing a class II 
MHC-restricted TCR (7). If correct, this hypothesis would 
indicate that the initial downregulation of either CD4 or CD8 
coreceptors by double positive cells undergoing positive se- 
lection occurs independently of the specificity of the TCR- 
a/B,  at least in a subset of developing cells. 
The initial observations concerning mature T cells in TCR- 
ol/B transgenic  mice were confirmed in class  I  or class  II 
MHC-deficient mice which essentially lacked mature single 
positive  CD4-8 +  and  CD4+8 -  cells,  respectively,  even 
though small numbers of cells belonging to the respective 
subsets could he detected (8, 9). The specificity of the TCIL- 
c~/B  on these cells  was unknown. 
1 Abbreviations used in this paper: B2m, ~2-microglobulin; HSA, heat-stable 
antigen; Rag-2, recombination-activating gene 2. 
There were also reports on the existence of CD4 § T cells 
that could recognize class I MHC antigen (10-12). Unfortu- 
nately it was not clear whether this was simply due to some 
crossreactivity of class II MHC-selected cells, or whether these 
cells were selected by class  I  MHC molecules. 
Here we present  another  apparent  exception to the rule 
of"matched" specificity of coreceptor and TCR-cr/~ on ma- 
ture T  cells.  We have analyzed TC1L transgenic  mice with 
a TCR specific  for peptide 111-119 from influenza hemag- 
glutinin presented by I-E a class II MHC molecules. In these 
mice, we have detected a small but significant portion of ma- 
ture CD4-8 + T  cells with the transgenic TCIL-a/B,  even 
when the transgenic  mice were rearrangement  defective or 
lacked  endogenous  TCR-a  genes.  The  CD4-8 +  T  cells 
responded with proliferation  and differentiation  into cyto- 
lytic T  cells when  stimulated by peptide plus I-E  a class II 
MHC molecules. Positive selection of these cells required I- 
E d class II MHC molecules in the thymus. Full maturation 
of these cells,  however, also required the presence of class I 
MHC molecules. 
In accord with previous data, our results indicate that down- 
regulation of the CD4 coreceptor does not require binding 
of the TCR-oJ~ to thymic class I MHC molecules, at least 
in a subset of developing cells;  yet class I MHC molecules 
are  required  for  full  maturation  of  these  CD4-8 +  cells 
bearing  a class II MHC-restricted  TCR. 
Materials and Methods 
Mice.  BALB/c and C56BL/6 (B6) mice were obtained from 
IFFA-Credo  (France).  B10.GD mice,  of H-2  s2  haplotype  (13), 
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Figure  1.  Thymus (A) and lymph nodes (B) of TCR transgenic mice on H-2  d and H-2  b MHC haplotype. Single cell suspensions of thymus or 
lymph nodes from transgenic BALB/c and B6 (F2) mice were used for three colour immunofluorescence. Lymphocytes  were depleted of slg + cells 
before staining. Absolute numbers were 8.3  x  107 and 10.7 x  107 thymocytes and 6.5  x  10r and 7.0  x  107 lymphocytes in H-2  a and H-2  b mice, 
respectively. All CD4+8 -  and CD4-8 + mature T cells stained homogeneously positive with TCR V0s-specific mAbs. 
were obtained from Dr. van Mourik (Netherlands  Red Cross Blood 
Transfusion Service, Amsterdam, Netherlands). The various gene- 
targeted mice used for this study have been described.  Homozy- 
gous mutant mice, deficient for (a) recombination-activating gene 
2 (Rag-2 -/-) (14), (b) TCR-tx constant region (TCRc~E  -/-) (15) 
or (c)/~m -/-  (8) were obtained by intercrossing F1 offspring of 
homozygous mutant H-2  b (a, c) or H-2  a (b) and TCR transgenic 
H-2  a mice.  Mice expressing  hemagglutinin have the hemagglu- 
tinin  transgene  under  control  of Ig g  promoter  and  enhancer 
elements (Rolink, A., manuscript in preparation).  All breeding was 
done in the animal colony of the Basel Institute for Immunology. 
Phenotyping of offspring was done by FACS  |  (Becton Dick- 
inson & Co., Mountain View, CA) staining of PBLs. TCR trans- 
genic,  as well as TCR transgenic mice deficient  in either Rag-2 
or TCRc~ genes,  were identified  by staining  PBLs  with  TCR 
Vfls- and clonotype-specific  mAbs. 
MHC haplotype and fl2m deficiency was revealed by staining 
PBLs with mAbs specific for D a, K b, I-Aft  d, or I-A  b molecules.  If 
necessary, TCR transgene presence was determined by Southern 
blotting. 
Mice were killed  between 6 and 10 wk of age. 
Cell Suspensions and B or T  Cell Depletion.  Single cell suspen- 
sions of thymus, lymph nodes, and spleen (RBCs lysed) were pre- 
pared  in  PBS  +  2%  FCS.  slg § cells were depleted  using Dy- 
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nabeads  (Milan  Analytica,  La  Roche,  Switzerland).  In  some 
experiments T cells were depleted by staining with Thy-l-specific 
mAbs followed by complement  (Low-Tox Rabbit Complement; 
Cedarlane Laboratories Ltd., Hornby, Ontario, Canada) treatment, 
as recommended by the manufacturer. 
Antibodies and FACS  |  Analysis.  Hybridoma supernatants con- 
taining mAbs were purified by protein A or protein G (Pharmacia 
LKB, Uppsala, Sweden) affinity chromatography,  mAbs were la- 
beled using biotin-  or  fluoresceine-succinimidyl-ester  (FLUOS) 
(Boehringer Mannheim,  Mannheim,  Germany) or FITC (Nordic 
Immunology, Tilburg,  Netherlands)  according to the manufacturers 
instructions. The following mAbs have been used: T19.191 (Anti- 
D a) (H~immerling,  G. J., unpublished results), AF6-88.5.3 (anti- 
K b) (16),  MKD6  (anti-I-Aa a) (17),  AF6-120.1.2  (anti-I-A b) (16), 
T24  (anti-Thy-1)  (18),  M5/114  (anti-I-A  b'a'q, anti-I-E b'a'~) (19), 
M1/69 (anti-heat-stable  antigen [HSA]) (20), F23.1 (anti-TCR V~s 
(21), and 6.5 (anticlonotypic TCR). The 6.5 mAb was produced 
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in rats immunized  with the soluble TCR obtained as described 
in (22). 
Biotinylated or FITC-labeled F23.1 and FLUOS-labeled 6.5 mAbs 
were used for TCR detection. Anti-CD8-biotin (Becton Dickinson 
& Co.), anti-CD8-PE (Cahag Laboratories, S. San Francisco,  CA), 
anti-CD4-PE  (Becton Dickinson  &  Co.) and anti-CD8-Red613 
(GIBCO BILL, Gaithersburg, MD) conjugates were obtained com- 
mercially.  Class  II MHC expression was determined by staining 
with M5/114 mAbs; HSA-specific mAbs M1/69 were biotinylated. 
With these and second step reagents streptavidin-allophycocyanin 
(APC,  Molecular  Probes  Inc.,  Eugene,  OIL),  streptavidin-PE 
(Southern Biotechnology, Birmingham,  AL) or goat anti-mouse 
Ig-F(ab)2-FITC (Silenus Laboratories,  Pty Ltd., Hawthorne, Vic- 
toria, Australia)  one-, two-, three-, and four-color flow cytometry 
was  performed  on  FACScan |  FACStar +|  or  FACS-Vantage | 
(Becton Dickinson & Co.) instruments  equipped appropriately. 
Staining was done in 96-well plates (106 cells/well) in  100/~1 PBS  +  2% FCS with mAbs at optimal dilution as determined 
before. Between first and second step reagents cells were washed 
twice with 200/~1 PBS + 2% FCS as was done after the last step. 
Data (up to 5  x  10  s events) were stored in list mode and ana- 
lyzed with the Lysys  II software (Becton Dickinson & Co.). Dead 
cells were excluded  using forward- and side-scatter  parameters. Data 
are presented as dot-plots showing all cells fulfilling the gating 
criteria. Numbers in quadrants, regions, or histograms indicate the 
proportion of  cells in that area. As far as analyzed data from lymph 
nodes or spleen gave similar results. 
Primary MLR and Killer Assay.  To generate cytolytic effector 
cells 107 responder cells were cultured with 107 x-irradiated stimu- 
lator cells (2,200 tad) in 8 ml IMDM supplemented  with FCS (10%), 
3-mercaptoethanol  (5  x  10 -5 M), penicillin (100 IU/ml), and 
streptomycin (100 mg/ml) (referred to as medium hereafter)  in flasks 
that were kept in an upright position.  To some flasks, peptide 
110-119 of influenza hemagglutinin (SFERFEIFPK) was added at 
a final concentration of 7.5 #M. In other experiments spleen cells 
from hemagglutinin transgenic mice were used as stimulators or 
cultures contained an chimeric mAb (2.5 /~g/ml) including the 
111-119 epitope (23). Cultures were kept in a water-saturated at- 
mosphere of 6% CO2 in air at 37~  for 4-5 d. 
To separate CD4+8 - from CD4-8 + effector  cells, cultures were 
set up in upright big flasks at the same cell concentrations.  Effectors 
were harvested at day 4, dead cells removed by centrifugation over 
Ficoll (Pharmacia LKB) and cells stained with CDf-FITC (Becton 
Dickinson & Co.) and CD4-PE specific mAbs followed by cell 
sorting. 
Target LPS blasts were generated from T cell depleted, Con A 
blasts from slg § depleted spleen cells. 3  x  107 cells were cultured 
in 30 ml of medium containing either 50 #g/ml LPS or 2.5 #g/ml 
Con A. Cells were harvested  48 h later. LPS blasts were centrifuged 
over Ficoll; Con A blasts were treated for 30 min with 50 mM 
C~-D-methylmannopyranoside  (Sigma  Chemical  Co., St. Louis,  MO). 
Blasts were washed, pelleted, and 50-150/~1 Na2SlCrO4 was added 
together with 20/~1 IMDM or 20/~1 of 1 mM peptide 110-119 
in IMDM. Cells were loaded for 1 h at 37~  and washed three 
times before adding to the killer assay. 
2  x  104 target cells were incubated with various numbers of 
responder cells for 4 h at 37~  in 200/~1 medium as duplicates 
in round-bottom 96-well plates. Effector/target ratios were calcu- 
lated from the number of responder cells initially cultured,  the 
descendants of which are the effector cells lysing target cells on 
day 4 or 5. Some wells received only target cells, to others Zap-O- 
Globin (Coulter Corp., Hialeah, FL) was added, to determine spon- 
taneous and total release, respectively. After the incubation period 
plates were spun briefly and 100/~1 supernatant was harvested. Data 
are presented as percent specific SlCr release calculated as follows: 
percent specific release =  [(experimental release -  spontaneous 
release)/(total release -  spontaneous release)] x  100. Spontaneous 
release was below 15% of total release; standard deviations were 
below 10%. 
Results 
TCR 7?ansgenic Mic~  The productively rearranged TCtL-ol 
and 3 genes were cloned from a T cell hybridoma 14.3.d (de- 
rived  from  a  T  helper  clone  V2-1s) specific  for  peptide 
111-119 of influenza hemagglutinin (24) presented by class 
II bE  d MHC molecules as described previously (22,  25). 
The receptor is encoded by Va8.2, Ja2.1 as well as V,~4, Jcc2B4 
variable  TCtL gene segments. Genomic DNA was injected 
into fertilized (B6  x  DBA/2J)F2  eggs.  Since initially the 
transgenic offspring showed little expression of the transgenic 
TCR-o~ gene, the TCR-3 enhancer was introduced down- 
stream of the Cc~ enhancer. The resulting transgenic mice 
were backcrossed  for four to five generations to mice of the 
BALB or B6 background. 
Expression of TCg-cr  and fl  Genes.  As  expected  from 
previous results,  the transgenic mice exhibited an increased 
ratio of CD4 § to CD8 § single positive cells in the thymus, 
even  though <20%  of the  CD4 +  cells  stained with  the 
clonotypic 6.5 antibody. In fact, similarly skewed ratios were 
already seen in mice that expressed  only the TCR-3 trans- 
gene, irrespective  of whether the mice were of the b/b or 
d/d  MHC  haplotype  (our  unpublished  results).  It  is 
noteworthy that in the thymus of mice with the d/d but not 
the b/b MHC haplotype, a significant portion not only of 
the CD4 §  8-, but also of the CD4- 8 + cells, bear high levels 
of the transgenic TCR (Fig.  1 A). In lymph node cells, the 
proportions  of CD4-8 +  T  cells  with  high levels of the 
transgenic TCR are not really different in MHC b/b vs. d/d 
mice, presumably because of  peripheral  selection of  cells with 
endogenous TCR c~ chains in both types of mice such that 
most CD4-8 + express either low or only intermediate levels 
of the transgenic TCR cr  chain (Fig.  1 B). 
CD4-8 + T  Cells with the Transgenic TCR Are Stimulated 
to  Proliferate and  to  Kill  by  Class II MHC  Presented Pep- 
tide.  Spleen cells from the TCR transgenic mice were first 
stimulated by BALB/c spleen cells in the presence or absence 
of peptide and tested for cytotoxicity on LPS blasts (class II 
MHC +)  and  Con  A  blasts  (class II  MHC-)  with  or 
without peptides as targets. While both targets were equally 
lysed by B6 anti-BALB/c killer cells, only peptide-pulsed  LPS 
targets but not peptide-pulsed Con A targets were lysed (fig. 
2, A  and C). We also obtained effector cells by stimulating 
cells from TCR transgenic mice with spleen cells from a mouse 
that expresses hemagglutinin as a transgene under the con- 
trol of IgK promoter and enhancer (Rolink, A., manuscript 
in preparation). From the same mice LPS targets were pre- 
pared that were lysed by various effector cells (Fig. 2 C). These 
data, and other data (see Fig. 2, legend) with LPS blasts from 
I-E  d§  and I-E  d- mice, showed that all cytolytic T cells were 
specific for the class II MHC presented peptide 111-119. In 
Fig.  2  B,  CD4+8 -  effector  cells  were  separated  from 
CD4-8 + effector cells before the killer assay. It can be seen 
that CD4-8 § cells give rise to much more potent effector 
cells than CD4 +  8-  cells. 
CD4-8 ~  T  Cells with  the Class II MHC-restricted  Trans- 
genic TCR in RAG-2 -/-  or TCRcru -/- Mice.  To rule out 
the  possibility  that  CD4-8 +  T  cells  with  the  class  II 
MHC-restricted, transgenic TCR were positively selected 
because of additional receptors composed of endogenous TCR 
c~ chains associated with transgenic TCR/3 chains (26-28), 
the  TCR  transgenic mice were  crossed  with RAG-2 -/- 
and TCRc~E  -/-  mice.  From the intercrosses  we obtained 
TCR transgenic RAG-2-/-  and TCILc~-/- mice that were 
either of the d/d or b/b MHC haplocytes.  It can be seen in 
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Figure  2.  Transgenic effector cells are specific 
for peptide presented by class II bE  d MHC mol- 
ecules  (.4  and  C)  and  present  among  both 
CD4 + 8-  and CD4- 8 + cells (B). Spleen cells  of 
TCR  transgenic  mice  were  stimulated  with 
BALB/c spleen cells in presence or absence of pep- 
tide 110-119  (A-C) or with BALB/c hemagglu- 
tinin transgenic spleen cells (C). Effector cells were 
analyzed on day 4 or 5 on LPS (A-C) and Con 
A  (.4  and C) blasts,  some of them loaded with 
peptide 110-119 or obtained from hemagglutinin 
transgenic mice. LPS blasts were >90%  class II 
positive, whereas Con A blasts contained <5% class 
II positive cells as determined by flow cytometry 
(not shown). Spleen cells of TCR. transgenic mice 
stimulated in the absence of antigen generated no 
effector cells (at highest effector/target ratio below 
5 and 20% release in A  and C, respectively; not 
done in B). B6 anti-BALB/c effector cells  killed 
LPS and Con A  BALB/c targets  (+/-  peptide) 
to an similar extent,  e.g., >50%  at an effector/ 
target ratio of 10:1 in A, >80%  at 1:1 in C; not 
done in B. Peptide pulsed LPS blasts from I-Ea  a 
negative strains (see Table 1) were not killed. In 
B  effector cells  were generated  from  transgenic 
spleen cells and tested either unseparated  or after sorting into CD4*8-  or CD4-8 + cells.  The effector/target ratio  of sorted effectors was adjusted 
to equal the ratio of that population in the unseparated  effectors.  The increased lysis by CD4- 8 + sorted effectors compared to unseparated effectors 
might be due to removal of cold target cells carried over from the primary MLR in case of the latter. Contamination of CD4+8 -  effectors by CD4-8 + 
cells can not explain the extent of CD4+8--mediated  killing as it should exceed 5%  to explain the killing. However, cell-sorter reanalysis  showed 
that the actual contamination was well below this level. We also purified CD4+8 -  and CD4-8 + cells before the primary MLk and obtained similar 
results  (data  not  shown). 
Fig. 3 A  that significant numbers of mature CD4- 8 + cells 
with high levels  of the  transgenic TCR were  present  in 
the thymus of d/d but not b/b  transgenic mice. The few 
CD4-8 +  cells  in  the  RAG-2 -/-  b/b  mice were  mostly 
HSAhig  h and had lower levels of the TCR. and were thus, 
by these criteria, very immature cells, not affected by posi- 
tive  selection.  Thus,  both  CD4+8 -  as  well as  CD4-8 + 
cells with high levels of the transgenic TCR. required posi- 
tive selection on H-2  a MHC molecules (Fig.  3 A).  I-E0  a 
class II MHC molecules were required for the selection of 
29  Kirberg et al. A 
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Figure  3.  Thymus and lymph nodes in TCRoeE  -/-  and RAG-2 -/-  TCR transgenic mice. Thymocytes (.4) and peripheral cells (from lymph nodes, 
B) of various mice were prepared and used  for  four-color  flow cytometry.  CD4-8 + 6.5 + cells in lymph nodes  of H-2 b mice repeatedly had lower 
levels of CD8  as CD4-8 + 6.5 + cells in H-2 d mice. 
30  Thymic Selection  of CD8 + Class II MHC-restricted T Cells Table  1.  H-2 Haplotypes and Effect on Selection in  TCR  Transgenic Mice 
Alleles  at H-2 loci: 
K  A3  Aa  E3  Ea  D 
Positive  selection  of CD4+8 - 
and CD4-8 § 6.5  hi cells 
d  d  d  d  d  d 
H-2  d  d  d  d  d  d  d  + 
d  d  d  d  d  d 
H-2  a~b  b  b  b  b  b  b 
b  b  b  b  b  b 
H-2  b  b  b  b  b  b  b  - 
d  d  d  d  d  d 
H-2  dXg2  d  d  d  d  b  b  + 
d  d  d  d  b  b 
H-2~  2  d  d  d  d  b  b  - 
The crossover in E~g  2 has been localized to the intron between the E31 and E32 exons (35). The peptide presenting domain of the E~g  2 molecule 
is therefore of EO  d origin and E~g  2 is likely to behave like Ea  a as shown in this table. Positive selection of CD4-8+ 6.5  hi cells was never observed 
in the absence of positive selection of CD4+8 -  6.5  hi cells. 
both  subsets  of T  cells because they were absent  in H-2  b, 
H-2g  2,  (H-2  a  x  H-2b)rl  but  not  (H-2  a  x  H-2g2)rl TCR 
transgenic  mice (data not  shown).  The nonselecting mice 
are deficient in I-E  d molecules either because of the absence 
of I-Eo  a or I-E,, genes or because  I-Ea  d does  not  come to 
the cell surface in sufficient quantity like in (H-2  b  x  H-2a)r, 
hybrids  in  which  the  I-E~  b outcompetes  I-E~  a because  of 
its strong association with I-E~ molecules (29, 30, and our 
unpublished  results).  Thus,  neither  K d nor D a  molecules 
are sufficient  for  positive  selection  of the  CD4-8 +  cells 
with the class II MHC-restricted transgenic TCIL, but I-E~  d 
cell  surface expression is  required  (see Table  1). 
With regard to lymph nodes of the various mice, the pic- 
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Figure 4.  Thymocytes from 32m + and 32m- TCR transgenic mice of H-2  d or H-2  b MHC haplotype. Single cell suspensions of thymocytes were 
prepared from 8-10-wk-old mice and stained and analyzed by four-color flow cytometry. Total numbers of thymocytes (x  107) were 7.5 and 9.0 for 
H-2  b and 14.4 and 11.6 for H-2  a mice expressing or lacking 32m, respectively. 
31  Kirberg  et al. there  are  very few CD4+8 -  cells  in  the  lymph node of 
RAG-2-/-  H-2  b TCR. transgenic mice, there are few cells 
with low CD8 levels that express the transgenic receptor (2 
X  10  6) (Fig. 3 B). These cells may represent a different lin- 
eage of T cells that do not require positive selection and are 
more abundant in TCR transgenic than normal mice (31). 
Full Maturation of Class H MHC-restricted  CD4- 8 + Cells 
Requires Class I MHC Molecules.  To test whether CD4- 8 + 
T cells with a class II MHC-restricted TCR could be gener- 
ated in the absence of class I MHC molecules, we analyzed 
the thymus of TCR. transgenic, fl2m-/- mice of the d/d or 
b/b  MHC  haplotype (Fig.  4).  CD4-8 +  cells  with  high 
levels of the transgenic TCR were detected in both fl2m + 
or/32m -/-  H-2  d mice, but not in fl2m + or fl2m-/-  H-2  b 
mice. However, there was a clear-cut difference between the 
GD4- 8 + T cells with high levels of the transgenic TCR in 
H-2  d flzm + and fi2m-/- mice: in the former they were quite 
heterogeneous with regard to HSA expression,  whereas in 
the latter they all expressed higher levels of HSA. (Note that 
most CD4-8 + cells that were selected through the receptor 
composed of transgenic fl and endogenous TCIK ot chains 
in/32m + mice were absent in fl2m-/-  mice because  of the 
lack of class I MHC molecules.) These results indicate that 
the CD4-8 + T cells with the dass II MHG-restricted trans- 
genic TG1K are  undergoing positive  selection when their 
receptor binds to class II MHC molecules in the thymus, but 
that the full maturation into CD4-8 + HSA negative cells 
requires  the presence  of class I MHC molecules. 
For that reason  CD4-8 + cells  with high levels of the 
transgenic TCIK were virtually absent in lymph nodes of 
H-2  d fl2m-/- mice, as were cells with additional receptors 
containing endogenous TCR ot chains (Table 2).  In H-2  b 
mice we  are  able  to  detect  very few  CD4-8+6.5 hi cells. 
These cells may have been selected  through receptors  con- 
taining endogenous TCR ot chains (H-2  b fi~.m  + mice) or 
may belong to an abnormal subset as described above (H-2  b 
32m - /-  mice). 
Discussion 
Our results document the existence of mature CD4-8 + 
cells with a class II MHC-restricted TCR. These cells re- 
quire positive selection by class II MHC molecules.  Because 
CD4-8 § thymocytes with a class II MHC-restricted TCR 
are  also  present  in  32m -/-  mice,  our  data indicate that 
downregulation of CD4 coreceptors on developing CD4+8 § 
thymocytes does  not  necessarily  require  ligation  of the 
TCR-ot/3 to class I MHC molecules, at least in a fraction 
of developing cells. These data are in accord with the previ- 
ously published  data  that  demonstrated  the  existence  of 
CD4 +  8  l~  cells with a class I MHC-restricted TCR as well 
as CD41~  + cells in class II MHC-deficient mice (5). It has 
previously been assumed that the full maturation of single 
positive T  cells requires  coengagement of MHC molecules 
by the TCR-c~/fl as well as the respective coreceptor (3-7, 
32-34).  Our data suggest that there may be exceptions to 
this rule; we find that the presence of class I MHC molecules 
can induce the full maturation of CD4-8 + HSA  high T  cells 
into CD4-8 + HSA- cells, even though they express a class 
II MHC-restricted TCR. One reason for this might be that 
the transgenic dass II MHC-restricted TCR has some affinity 
for both class II and class I MHC molecules. We think that 
this is not a very likely explanation for several reasons. First, 
positive selection of cells with the transgenic TCR neces- 
sarily requires  class II MHC molecules.  Neither K a nor D a 
MHC molecules were sufficient for positive selection of cells 
with the transgenic TCR. Second, in very sensitive binding 
assays the soluble transgenic TCR failed to bind to class I 
MHC molecules, although binding to class II MHC mole- 
cules, even in the absence of the specific peptide, could easily 
be visualized (22,  Karjalainen, K., unpublished results).  It 
could thus be that for full maturation of some or~3 T cells, 
it suffices when the TCR-c~/3 binds to one class of MHC 
molecules (in our case class II) and the coreceptor to the other 
class (in our case class I). This may be sufficient with TCRs 
of relatively high affinity that can induce activation of ma- 
ture T cells in the absence of coreceptors, as has been reported 
for the transgenic TCR studied here (Karjalainen,  K., un- 
published results).  One might assume that some of these 
receptors  also have higher affinity for self MHC molecules 
in the absence of the specific peptide. Our data are consistent 
with the notion that the full maturation of or~3 T cells re- 
quires  more than a single interaction of the TCR-ot/3 or 
Table  2.  Cell Numbers (10  9 in Lymph Nodes  from fl2m + and flem-  TCR  Transgenic Mice of 1-1-2  d and H-2  b Haplotype 
CD4+8 -  CD4-8 § 
Total  6.5 hi  6.5 hi  6.5hiHSA  l~  6.5hiHSA- 
Tg 32m+H-2  a  22.2  20.0  1.30  2.06  0.28  0.07  0.21 
Tg 32m-H-2  a  27.1  26.8  1.75  0.04  0.01  0.01  <0.01 
Tg 32re+H-2  b  25.8  22.8  0.39  1.81  0.14  n.d.*  0.13 
Tg 32rn- H-2  b  23.5  22.7  0.30  0.05  0.03  n.d.  0.03 
* n.d., not detectable as too few cells were acquired to give an exact number. 
Absolute cell numbers of indicated cell populations in lymph nodes were calculated from total cell numbers and percentages of cells determined  by 
four-color immunofluorescence  as shown in Fig. 4. 
32  Thymic  Selection of CD8+ Class II MHC-restricted  T Cells CD4/CD8 coreceptors with intrathymic ligands (5). They 
also provide an exception to the rule that class II and class 
I MHC-restricted receptors are exclusively expressed by ma- 
ture CD4 + and CD8 + single positive T  cells, respectively. 
It  remains  to  be  seen  how  frequent  these  exceptions are 
which can only be rigorously tested in TCR transgenic mice 
that do not produce endogenous TCR proteins. Our results 
show further that CD4- 8 § T  cells can be activated by class 
II MHC-presented peptides to become potent killer cells. 
One could imagine that the activation of CD4- 8 + lytic T 
ceils  by  class  II  MHC-presented  peptides  could  be  of 
significance in regulating immune responses, for instance by 
destroying class II positive antigen-presenting cells. Such cells 
could also be of pathophysiological importance either in pro- 
tective immune responses or in autoimmunity. 
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